|
|
|
Receive Alerts Free For One Week! Short Term PowerRatings Use PowerRatings every day to find the stocks for tomorrow to focus on and the ones to avoid. Sign Up Now >>
Long Term PowerRatings
Gary Kaltbaum Intraday Breaking Setups
Kevin Haggerty's Professional Trading Service
|
This week's scan of the PowerRating Communities favorite stocks produces several interesting and newsworthy names across a variety of sectors. PowerRatings are based on a 12 year study of over 5 million trades across most market conditions and environments.
Unlike other research of this type, we used statistically valid methods and every day is equally weighted. This means if a stock has earned a 10 rating, every day it has the 10 rating its viewed one year ahead from that day, not simply on the day it is awarded the rating. This makes Long Term PowerRatings a truly dynamic tool for choosing stocks and evaluating your long term portfolio.
This week, many of the most popular stocks are low ranking Long Term PowerRated stocks. The low 1, 2 or 3 rated stocks have proven to simply be too volatile, thus risky for prudent, long term investment. Let's take a closer look at a few of these stocks our community is watching closely:
Goldman Sachs (GS | Quote | Chart | News | PowerRating) - This 2 rated behemoth of an investment banking firm has been cut by almost a third from its late 2007 highs. It has been in a steady downtrend due to the troubling world wide economic conditions that have crushed several of its brethren in similar businesses. Despite a positive private equity rise and government intervention into the sector, Goldman continues to have core troubles.
The third quarter results were dismal with diluted earnings per share of $1.81 compared to $6.13 for the same time in 2007. The good news is the company still has substantial market value at its current price of $87.43. They are still the number one ranked firm in the world for merger and acquisitions and their Security Services division actually beat last years net Revenues by 20%. One day soon, it may provide an excellent opportunity. Keep your eyes on this one and its Long Term PowerRating, its down but not out!

Pfizer (PFE | Quote | Chart | News | PowerRating) - This 5 rated drug company has dropped from its lofty 8 ranking over the last several months. They have reaffirmed guidance for the rest of 2008 and earnings were up in the third quarter. Technically, price has bounced off the $14.00/share low range and is currently trading at $17.00/share. It's still below the 50 and 200-day simple moving averages at $19.30 and $21.72, respectively. The stock is ranked as the 7th most popular stock on our community screener.

Johnson & Johnson (JNJ | Quote | Chart | News | PowerRating) - This drug company is the highest rated community favorite stock today with a 6 Long Term PowerRating. Price dropped precipitously at the start of October to a low of 52, but has now seems to have stabilized in the $60.00/share range. They reported an impressive 13.1% increase in worldwide sales and success with the U.S. launch of their ZYRTEC drug.

| Click here to start your free, 7-day trial to our Short Term PowerRatings! |
Learn what you need to know as an active investor looking to invest in companies with a history of financial strength and a track record for growth. Click the link above or call us at 888-484-8220 extension 1 to get your copy of the "5 Secrets to Successful Stock Investing" today!
David Goodboy is Vice President of Marketing for a New York City based multi-strategy fund.